Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A Primary Care Physician's Perspective on Benign Prostatic Hyperplasia.

Reviews in Urology

|September 21, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beyond diagnostic test performance: two content-validated questionnaires assessing patient and clinician satisfaction with diagnostic tests.

Journal of patient-reported outcomes·2025

Same author

Potential delayed and/or missed STI diagnoses among outpatients presenting with lower genitourinary tract symptoms: a real-world database study.

Postgraduate medicine·2023

Same author

Outpatient sexually transmitted infection testing and treatment patterns in the United States: a real-world database study.

BMC infectious diseases·2023

Same author

Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials.

Current medical research and opinion·2022

Same author

Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association.

Stroke·2021

Same author

Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care.

Annals of medicine·2021

Benign prostatic hyperplasia (BPH) symptoms can often be managed by primary care clinicians. Alpha-blockers offer prompt relief, but 5-alpha-reductase inhibitors are the only pharmacotherapy shown to modify the disease course.

Area of Science:

Urology
Primary Care Medicine
Pharmacology

Background:

Benign prostatic hyperplasia (BPH) is common in men.
Primary care clinicians are the first point of contact for symptomatic BPH.
Most BPH cases can be managed in an ambulatory setting.

Purpose of the Study:

To review the management of symptomatic benign prostatic hyperplasia in primary care.
To highlight the role of different pharmacotherapies in BPH management.
To emphasize the disease-modifying effects of 5-alpha-reductase inhibitors.

Main Methods:

Literature review of pharmacotherapies for BPH.
Analysis of treatment outcomes for alpha-blockers and 5-alpha-reductase inhibitors.
Discussion of clinical management strategies in primary care.

Related Experiment Videos

Main Results:

Alpha-blockers provide rapid symptom improvement, particularly for nocturia.
Alpha-blockers do not prevent disease progression or reduce the need for surgery.
5-alpha-reductase inhibitors are the only pharmacotherapy with a proven disease-modifying effect.

Conclusions:

Primary care clinicians should be familiar with both alpha-blockers and 5-alpha-reductase inhibitors for BPH management.
While alpha-blockers offer symptomatic relief, 5-alpha-reductase inhibitors address the underlying disease progression.
Appropriate pharmacotherapy selection is crucial for effective long-term BPH management.